Next Article in Journal
Oral Administration of the Japanese Traditional Medicine Keishibukuryogan-ka-yokuinin Decreases Reactive Oxygen Metabolites in Rat Plasma: Identification of Chemical Constituents Contributing to Antioxidant Activity
Previous Article in Journal
Bioactive Benzofuran Derivatives from Cortex Mori Radicis, and Their Neuroprotective and Analgesic Activities Mediated by mGluR1
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Special Issue on Ruthenium Complexes

by
Ileana Dragutan
1,*,†,
Valerian Dragutan
1,*,† and
Albert Demonceau
2,*,†
1
Institute of Organic Chemistry “C.D. Nenitescu”, Romanian Academy, 202B Spl. Independentei, 060023 Bucharest, P.O. Box 35-108, Romania
2
Department of Chemistry, University of Liège, Sart-Tilman (B.6a), 4000 Liège, Belgium
*
Authors to whom correspondence should be addressed.
These authors contributed equally to this work.
Molecules 2017, 22(2), 255; https://doi.org/10.3390/molecules22020255
Submission received: 25 January 2017 / Revised: 25 January 2017 / Accepted: 4 February 2017 / Published: 8 February 2017
(This article belongs to the Section Organometallic Chemistry)
The organic chemistry of ruthenium has been one of the most vigorously growing research areas over the past decades. Considerable effort has been extended towards the design and application of a broad series of ruthenium complexes, which culminated with the development by Ryoji Noyori (2001 Nobel Prize for Chemistry) of chiral ruthenium catalysts for stereoselective hydrogenation reactions [1], and the discovery by Robert H. Grubbs (2005 Nobel Prize for Chemistry) of well-defined ruthenium–benzylidene catalysts for olefin metathesis [2].
The aim of this special issue was to provide an overview of recent trends in ruthenium complex chemistry, hereby underlining its growing importance in the development of anticancer drugs and applications in catalysis, polymers, materials science, and nanotechnology [3].
The submitted contributions can be roughly grouped into four categories: (1) synthesis of new ruthenium complexes, (2) applications in organic synthesis and catalysis, (3) photocatalysis and dye-sensitized solar cells, and (4) medicinal chemistry. With the exception of the article of Igor T. Chizhevsky et al. [4], which deals with the synthesis and characterization of new closo-ruthena-carborane complexes with a dioxygen ligand, most of the contributions actually fall into two or even three categories, so that the following summary of the special issue is by no means a strict classification.
As one of these categories, organic synthesis and homogeneous catalysis have constituted for a long time a major field of application of ruthenium complexes. Along this line, Vincenzo Piccialli [5] reviews in this issue the chemistry of ruthenium tetroxide and perruthenate with a special emphasis on oxidation of alcohols and hydrocarbons, dihydroxylation of alkenes, oxidative cleavage of C–C double and triple bonds. New processes, synthetic applications, theoretical studies and unusual transformations mediated by these species are also covered in this review. The asymmetric transfer hydrogenation of imines catalyzed by the Noyori–Ikariya half-sandwich ruthenium complexes has been surveyed by Petr Kačer et al. [6]. Aspects highlighted in this review include the role of the N-arylsulfonyl moiety and that of the η6-coordinated arene of the catalytic systems, and also the effect of structural modifications on the imine substrate. The supremacy of ruthenium–benzylidene complexes in olefin metathesis is illustrated by a contribution of Hermanus C. M. Vosloo et al. [7], who synthesized new chelating pyridinyl-alcoholato ligands and incorporated them into the second-generation Grubbs catalyst. The influence of the ligand substituents on the thermal stability, activity, selectivity and lifetime of these complexes in the metathesis of 1-octene has been investigated. On the other hand, the development of recyclable catalysts is nowadays a major trend towards sustainable chemistry. In their excellent micro-review, Dong Wang and Didier Astruc [8] focused their attention on the fabrication of recoverable magnetic nanoparticle-supported ruthenium complexes and their catalytic applications in various organic syntheses.
With many potential applications in photochemistry, ruthenium complexes have always been in the focus of synthetic organometallic chemists. A contribution to this category was made by Ludovic Troian-Gauthier and Cécile Moucheron [9] reviewing the photophysics reported in the literature for mononuclear, binuclear and polynuclear ruthenium complexes bearing ligands with extended aromaticity. Of these, binuclear complexes with extended π-systems finding practical applications in photocatalysis are treated in more detail. In the same direction, Adewale O. Adeloye and Peter A. Ajibade [10] have surveyed recent advances in the chemistry of ruthenium polypyridine complexes that have been designed and synthesized for use as photosensitizers in dye-sensitized solar cells. Special attention was paid to the correlation of the ligand structure with the photophysical, electroredox and power conversion efficiency of representative ruthenium polypyridyl complexes as well as to ruthenium complexes containing new polypyridine ligands with long-range electron transfer motifs such as alkenyl, alkynyl and polyaromatic donor functionalities.
The fourth category comprises possible applications of bioactive ruthenium complexes. Lusiane Maria Bendhack et al. [11] have reviewed the effects of ruthenium-derived NO donor complexes on the control of vasodilatation and arterial pressure. In particular, the crucial importance of the chemical structure of these ruthenium complexes for their vascular effects has been emphasized. Fernando Rogério Pavan et al. [12] reported on the in vitro anti-tuberculosis activity and cytotoxicity of ruthenium compounds encapsulated in nanostructured lipid systems composed of cholesterol, surfactant, and aqueous phase. Finally, Claudio L. Donnici [13] investigated the in vitro antifungal activity of a series of ruthenium dithiocarbamate complexes against different fungal species of clinical interest and related to invasive fungal infections. Very promising results were obtained and a preliminary structure–activity relationship was established.
At this point, we would like to thank all contributors for the submission of their articles, which allow this special issue to provide a comprehensive view of the current developments in the chemistry of ruthenium complexes, thus proving that modern chemistry is today indeed more ruthenium-dependent than ever before. Our sincere acknowledgements also go to the numerous referees who spent their time and attention to give helpful advice for improvements. Thanks are also due to the editorial staff of Molecules for their valuable support in perfecting this Special Issue.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Noyori, R. Asymmetric Catalysis: Science and Opportunities (Nobel Lecture). Angew. Chem. Int. Ed. 2002, 41, 2008–2022. [Google Scholar] [CrossRef]
  2. Grubbs, R.H. Olefin-Metathesis Catalysts for the Preparation of Molecules and Materials (Nobel Lecture). Angew. Chem. Int. Ed. 2006, 45, 3760–3765. [Google Scholar] [CrossRef] [PubMed]
  3. Dragutan, I.; Dragutan, V.; Demonceau, A. The Expanding Chemistry of the Ruthenium Complexes. Molecules 2015, 20, 17244–17274. [Google Scholar] [CrossRef] [PubMed]
  4. Kostukovich, A.Y.; D’yachihin, D.I.; Dolgushin, F.M.; Smol’yakov, A.F.; Godovikov, I.A.; Chizhevsky, I.T. An Unusual Conversion of Paramagnetic [3-Cl-3,3,8-{Ph2P(CH2)nPPh-µ-(C6H4-ortho)}-1,2-(CH3)2-closo-3,1,2-RuIIIC2B9H8] (n = 3 and 4) to Form the First 18-Electron P-Phenylene ortho-Cycloboronated closo-Ruthenacarboranes with a Dioxygen Ligand. Molecules 2014, 19, 7094–7103. [Google Scholar] [CrossRef] [PubMed]
  5. Piccialli, V. Ruthenium Tetroxide and Perruthenate Chemistry. Recent Advances and Related Transformations Mediated by Other Transition Metal Oxo-species. Molecules 2014, 19, 6534–6582. [Google Scholar] [CrossRef] [PubMed]
  6. Václavík, J.; Šot, P.; Pecháček, J.; Vilhanová, B.; Matuška, O.; Kuzma, M.; Kačer, P. Experimental and Theoretical Perspectives of the Noyori-Ikariya Asymmetric Transfer Hydrogenation of Imines. Molecules 2014, 19, 6987–7007. [Google Scholar] [CrossRef] [PubMed]
  7. Du Toit, J.I.; Jordaan, M.; Huijsmans, C.A.A.; Jordaan, J.H.L.; van Sittert, C.G.C.E.; Vosloo, H.C.M. Improved Metathesis Lifetime: Chelating Pyridinyl-Alcoholato Ligands in the Second Generation Grubbs Precatalyst. Molecules 2014, 19, 5522–5537. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  8. Wang, D.; Astruc, D. Magnetically Recoverable Ruthenium Catalysts in Organic Synthesis. Molecules 2014, 19, 4635–4653. [Google Scholar] [CrossRef] [PubMed]
  9. Troian-Gautier, L.; Moucheron, C. RutheniumII Complexes bearing Fused Polycyclic Ligands: From Fundamental Aspects to Potential Applications. Molecules 2014, 19, 5028–5087. [Google Scholar] [CrossRef] [PubMed]
  10. Adeloye, A.O.; Ajibade, P.A. Towards the Development of Functionalized Polypyridine Ligands for Ru(II) Complexes as Photosensitizers in Dye-Sensitized Solar Cells (DSSCs). Molecules 2014, 19, 12421–12460. [Google Scholar] [CrossRef] [PubMed]
  11. Galvão de Lima, R.; Rodrigues Silva, B.; Santana da Silva, R.; Bendhack, L.M. Ruthenium Complexes as NO Donors for Vascular Relaxation Induction. Molecules 2014, 19, 9628–9654. [Google Scholar] [CrossRef] [PubMed]
  12. Sinesio de Freitas, E.; Bento da Silva, P.; Chorilli, M.; Azevedo Batista, A.; de Oliveira Lopes, E.; Martins da Silva, M.; Queico Fujimura Leite, C.; Pavan, F.R. Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of Ruthenium(II) Compounds. Molecules 2014, 19, 5999–6008. [Google Scholar] [CrossRef] [PubMed]
  13. Donnici, C.L.; Nogueira, L.J.; Araujo, M.H.; Rodrigues Oliveira, S.; Magalhães, T.F.F.; Lopes, M.T.P.; Araújo e Silva, A.C.; da Costa Ferreira, A.M.; Martins, C.V.B.; de Resende Stoianoff, M.A. In Vitro Studies of the Activity of Dithiocarbamate Organoruthenium Complexes against Clinically Relevant Fungal Pathogens. Molecules 2014, 19, 5402–5420. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Dragutan, I.; Dragutan, V.; Demonceau, A. Special Issue on Ruthenium Complexes. Molecules 2017, 22, 255. https://doi.org/10.3390/molecules22020255

AMA Style

Dragutan I, Dragutan V, Demonceau A. Special Issue on Ruthenium Complexes. Molecules. 2017; 22(2):255. https://doi.org/10.3390/molecules22020255

Chicago/Turabian Style

Dragutan, Ileana, Valerian Dragutan, and Albert Demonceau. 2017. "Special Issue on Ruthenium Complexes" Molecules 22, no. 2: 255. https://doi.org/10.3390/molecules22020255

Article Metrics

Back to TopTop